Post by
Noteable on Jun 22, 2023 10:36am
ONCY pelareorep selected for Phase 3 Pancreatic Cancer trial
This is a significant development. PanCAN created the Precision Promise adaptive clinical trial because traditional clinical trial designs are slow to evaluate new treatment options for pancreatic cancer patients. PanCAN’s novel clinical trial platform is designed to more efficiently test new therapies for their effectiveness in treating patients with pancreatic cancer by requiring fewer patients to understand if a potential new therapy is working. The platform is also designed to allow multiple investigational therapies to be tested simultaneously.
https://pancan.org/research/precision-promise/
PanCAN’s Precision Promise Clinical Trial Consortium of over 20 clinical sites were selected through a competitive, peer-review process and include premier cancer treatment institutions across the country.
https://pancan.org/research/precision-promise/locations/
Comment by
Noteable on Jul 01, 2023 3:31pm
From PanCan's website .."Precision Promise is designed to serve as a catalyst to accelerate pancreatic cancer drug development, de-risk industry participation, increase clinical trial enrollment and transform the way clinical research is done for pancreatic cancer patients."
Comment by
fox7mf on Jul 02, 2023 9:30am
$1b buyout with 100m shares would suck...we all know this. Bloating matters.